Scarica l'app Stockscreener
214.05
0.96%
2.03
Dopo l'orario di chiusura:
214.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$212.02
Aprire:
$211.51
Volume 24 ore:
1.50M
Relative Volume:
0.87
Capitalizzazione di mercato:
$50.37B
Reddito:
$244.67B
Utile/perdita netta:
$1.68B
Rapporto P/E:
30.80
EPS:
6.9487
Flusso di cassa netto:
$5.51B
1 W Prestazione:
+3.06%
1M Prestazione:
-6.89%
6M Prestazione:
+35.08%
1 anno Prestazione:
+54.36%
Intervallo 1D:
$210.45
$214.56
Intervallo di 1 settimana:
$205.35
$214.56
Portata 52W:
$120.72
$233.60
Cardinal Health Inc Stock (CAH) Company Profile
Nome
Cardinal Health Inc
Settore
Industria
Telefono
(614) 757-3033
Indirizzo
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH vs MCK, COR, HSIC, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
214.05 | 50.37B | 244.67B | 1.68B | 5.51B | 6.9487 |
MCK
Mckesson Corporation
|
884.28 | 108.31B | 397.96B | 4.55B | 9.64B | 34.77 |
COR
Cencora Inc
|
324.80 | 63.18B | 325.78B | 1.64B | 3.61B | 8.3139 |
HSIC
Henry Schein Inc
|
73.94 | 8.48B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
2.22 | 1.90B | 14.85M | -136.07M | 7.23M | -0.4726 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-06-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-01-08 | Aggiornamento | TD Cowen | Hold → Buy |
| 2025-01-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-12-13 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-09 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Underweight |
| 2023-07-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Iniziato | Citigroup | Neutral |
| 2023-02-03 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Ripresa | Morgan Stanley | Overweight |
| 2022-05-26 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2021-08-06 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Downgrade | BofA Securities | Buy → Underperform |
| 2021-05-10 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-05-15 | Aggiornamento | UBS | Neutral → Buy |
| 2020-04-23 | Ripresa | Credit Suisse | Neutral |
| 2020-03-20 | Aggiornamento | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-08-27 | Downgrade | Argus | Buy → Hold |
| 2019-08-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-04-18 | Iniziato | Guggenheim | Neutral |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2018-11-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-03-08 | Iniziato | Barclays | Equal Weight |
| 2018-02-27 | Ripresa | BofA/Merrill | Underperform |
| 2018-01-05 | Iniziato | Evercore ISI | In-line |
Mostra tutto
Cardinal Health Inc Borsa (CAH) Ultime notizie
Longtime supervisor sues Cardinal Health over age and gender bias - hcamag.com
Cardinal Health, Inc. (CAH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Cardinal Health, Inc. (CAH) stock price, news, quote and history - Yahoo Finance UK
Cardinal Health ER Laceration Tray ACS-SLAC1 | Health Supply 770 INC - primetimes.id
Cardinal Health (NYSE:CAH) Upgraded at Wall Street Zen - MarketBeat
Global Clinical Drainage Supplies Market Dominated by North America as Cardinal Health and Medline Expand Products - WFMZ.com
Wells Fargo raises outlook on Cardinal Health (CAH), cites broad business strength - MSN
Tema Etfs LLC Trims Cardinal Health Stock Position - National Today
Tema Etfs LLC Decreases Stock Position in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health Increases Ac-225 Production to Enhance Cancer Treatment Options - Bitget
Cardinal Health Expands Ac-225 Capacity to Boost Cancer Therapies - finance.yahoo.com
HF Advisory Group LLC Buys 5,049 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Kwmg LLC Has $16.51 Million Position in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health Deepens Actinium-225 Role As Board Leadership Shifts - finance.yahoo.com
Cardinal Health, Shine Technologies amp up domestic production of radiopharmaceuticals - Healthcare Brew
Cardinal Health (CAH) Boosts Actinium-225 Production for Future Therapies - GuruFocus
Can CAH's Specialty Flywheel Strategy Unlock Long-Term Growth? - The Globe and Mail
Cardinal Health (CAH) Boosts Actinium-225 Production Capacity - GuruFocus
Insiders At Cardinal Health Sold US$53m In Stock, Alluding To Potential Weakness - Yahoo Finance
Nisa Investment Advisors LLC Trims Stock Position in Cardinal Health, Inc. $CAH - MarketBeat
Cancer drug developers get more Actinium-225 as Cardinal Health expands - Stock Titan
List of 30 Acquisitions by Cardinal Health (Apr 2026) - Tracxn
Can CAH’s Unique Specialty Flywheel Approach Drive Sustainable Growth Over Time? - Bitget
Cardinal Health, Inc. (NYSE:CAH) Short Interest Up 21.1% in March - MarketBeat
Did Cardinal Health's (CAH) New Chair and Urology Deal Just Reframe Its Healthcare Partnership Strategy? - Sahm
Cardinal Health (CAH) Increases Yet Falls Behind Market: What Investors Need to Know - Yahoo Finance Singapore
Cardinal Health Inc. stock rises Tuesday, still underperforms market - MarketWatch
3 Dividend Stocks With High Returns on Invested Capital - Investing.com
Here's why you should add Cardinal Health stock to your portfolio now - MSN
Cardinal Health, Inc. $CAH Shares Sold by Wedge Capital Management L L P NC - MarketBeat
-0.54% for Cardinal Health stock as price stays below key moving averages - Traders Union
Jim Cramer on Cardinal Health: "I want you to buy it and buy it, get this, aggressively" - MSN
Jim Cramer on Cardinal Health: “I Want You to Buy It and Buy It, Get This, Aggressively” - Insider Monkey
UBS reiterates Buy on Cardinal Health stock, $260 price target - Investing.com
Global X Japan Co. Ltd. Increases Position in Cardinal Health, Inc. $CAH - MarketBeat
Bethlehem - dailyvoice.com
Cardinal Health (CAH) Stock Moves -1.71%: What You Should Know - Yahoo Finance
Why The Narrative Around Cardinal Health (CAH) Is Shifting With New Targets And Guidance - Yahoo Finance
Cardinal Health Inc. stock outperforms competitors despite losses on the day - MarketWatch
Vanguard (CAH) parent reports zero CAH holdings after realignment - Stock Titan
Cardinal Health (CAH) Appoints New Chair as Gregory Kenny Steps Down - insidermonkey.com
Alcohol Prep Pads Recalled Over Bacteria Risk, Cardinal Health Says - Infectious Disease Advisor
Cardinal Health Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Cardinal Health Inc. stock faces steady trading amid distribution sector pressures and healthcare su - AD HOC NEWS
Cardinal Health appoints Patricia Hemingway Hall board chair - drugstorenews.com
Cardinal Health (CAH) Emerged as a Key Contributor on Pharmaceutical Strength and Margin Expansion - Yahoo Finance
Pensionfund Sabic Invests $1.79 Million in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health Names New Chair As Valuation And Momentum Diverge - Sahm
Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2026 on April 30 - Sahm
Avanza Fonder AB Lowers Stake in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health Inc. stock shows steady trading on NYSE amid healthcare supply chain pressures and u - AD HOC NEWS
Cardinal Health Inc Azioni (CAH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.25%
4.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):